Catalogo dei prodotti della ricerca

MICOZZI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.076
AS - Asia 2.836
EU - Europa 1.622
SA - Sud America 479
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 10.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.975
SG - Singapore 1.191
IT - Italia 560
CN - Cina 494
BR - Brasile 394
VN - Vietnam 356
HK - Hong Kong 303
IN - India 262
SE - Svezia 192
FI - Finlandia 167
DE - Germania 159
UA - Ucraina 120
FR - Francia 96
RU - Federazione Russa 90
CA - Canada 63
GB - Regno Unito 62
AR - Argentina 51
IE - Irlanda 41
ZA - Sudafrica 33
BD - Bangladesh 32
JP - Giappone 31
BG - Bulgaria 27
ID - Indonesia 22
IQ - Iraq 22
MX - Messico 20
NL - Olanda 17
PK - Pakistan 15
AT - Austria 14
EC - Ecuador 14
KR - Corea 14
TR - Turchia 14
UZ - Uzbekistan 14
BE - Belgio 12
PL - Polonia 12
SA - Arabia Saudita 12
TG - Togo 11
MA - Marocco 10
ES - Italia 8
PH - Filippine 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
CO - Colombia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
MY - Malesia 6
PY - Paraguay 6
CI - Costa d'Avorio 5
DK - Danimarca 5
LT - Lituania 5
VE - Venezuela 5
AU - Australia 4
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
GR - Grecia 4
JM - Giamaica 4
KE - Kenya 4
SC - Seychelles 4
SM - San Marino 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EU - Europa 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
CL - Cile 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BW - Botswana 1
BY - Bielorussia 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
Totale 10.109
Salva come PNG Salva come JPEG
Città #
Singapore 660
Fairfield 559
Ashburn 422
San Jose 326
Hong Kong 290
Chandler 278
Woodbridge 278
Ann Arbor 225
Houston 204
Seattle 201
Cambridge 195
Wilmington 181
Dearborn 168
Rome 160
Princeton 143
Beijing 127
San Paolo di Civitate 118
The Dalles 111
Ho Chi Minh City 106
Los Angeles 104
Plano 94
Hanoi 92
Boston 80
Lauterbourg 77
Lawrence 74
Santa Clara 72
Dallas 64
Buffalo 62
Des Moines 54
San Diego 52
Frankfurt am Main 49
Helsinki 49
New York 43
Dublin 40
Munich 40
Jacksonville 36
Hillsboro 35
São Paulo 35
Toronto 32
Redondo Beach 30
Tokyo 30
Milan 27
Sofia 27
Boardman 26
Johannesburg 26
Andover 23
Millbury 22
Bremen 20
Council Bluffs 19
Turku 19
Federal 17
Haiphong 17
Norwalk 17
Moscow 16
Da Nang 15
Cosenza 14
Guangzhou 14
Hefei 14
Tashkent 14
Rio de Janeiro 13
Brussels 12
Falkenstein 12
Shanghai 12
Jakarta 11
Lomé 11
Baghdad 10
Chicago 10
Naples 10
Yubileyny 10
Denver 9
Dhaka 9
Lappeenranta 9
London 9
Tianjin 9
Adelfia 8
Brasília 8
Bühl 8
Casablanca 8
Columbus 8
Curitiba 8
Falls Church 8
Kunming 8
Nuremberg 8
Orem 8
Ottawa 8
Biên Hòa 7
Bologna 7
Brooklyn 7
Campinas 7
Istanbul 7
Nanjing 7
Riyadh 7
Amsterdam 6
Atlanta 6
Bengaluru 6
Buenos Aires 6
Chengdu 6
Guayaquil 6
Montreal 6
Sacramento 6
Totale 6.684
Salva come PNG Salva come JPEG
Nome #
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC). 192
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 165
Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? 161
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae 157
Successful treatment of Brucella melitensis endocarditis with pefloxacin. 156
Infections by ampicillin-resistant enterococci: a case-control study. 152
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. 152
A rare case of coexisting breast cancer and refractory acute myeloid leukemia 151
BAVC regimen and autograft for acute myelogenous leukemia in second complete remission 149
4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin. 148
Efficacy and safety of long term tenofovir in high risk patients with hematological malignancies (HM) to prevent Hepatitis B Virus (HBV) reactivation after immunosuppressive therapies in real life 147
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome 146
Riattivazione dell’infezione cronica da virus dell’epatite C in pazienti affetti da malattie ematologiche maligne linfoidi o mieloidi riceventi chemioterapia e/o immunoterapia. Motivazione: Progetto fattibile, con buon razionale scientifico. Presumibili ricadute positive sulla cura dei pazienti 144
A multicenter, double blind, placebo-controlled trial comparing piperacillin/tazobactam with and without amikacin as empiric therapy for febrile neutropenia 141
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic 139
Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients 137
Candida colonization and systemic infection in neutropenic patients. A retrospective study. 134
Central venous catheterization in pediatric patients affected by hematological malignancies. 127
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. 127
Ara-C, idarubicine and Gentuzumab ozogamicin (AIM) as salvage treatment in advanced acute myeloid leukemia patients 120
Antimicrobial susceptibility, biochemical and genetic profiles of Staphylococcus haemolyticus strain isolated from the bloodstream of patients hospitalized in critic care units 120
Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: A prospective experience at an Italian Center 119
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study 117
Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. 110
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study 109
Galactomannan detection in Geotrichum capitatum invasive infections: report of 2 new cases and review of diagnostic options 108
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients 108
Piperacillin/tazobactam/amikacin versus Piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. 107
Enterococcal septicemia in patients with hematological malignancies 106
Cryptosporidiosis in patients with hematologic malignancies 106
Speculations on the clinical significance of asymptomatic viral infections 105
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient 104
Antibiotic prophilaxis in general surgery: Single dose vs Short term prophylaxis 103
SPECIES IDENTIFICATION AND DETECTION OF OXACILLIN RESISTANCE IN COAGULASE-NEGATIVE STAPHYLOCOCCUS BLOOD ISOLATES FROM NEUTROPENIC PATIENTS 102
Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production 101
Letermovir Prophylaxis for Cytomegalovirus 100
Successful management of a chronic refractory leg ulcer in an adolescent with sickle cell anemia 100
Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies 98
EMERGENCE OF PENICILLIN-RESISTANT VIRIDANS STREPTOCOCCI CAUSING SEPTICEMIA IN GRANULOCYTOPENIC PATIENTS 98
Peripherally inserted central catheter in patients with acute myeloid leukemia. Incidence and risk factors for premature removal 97
FUNGEMIA IN PATIENTS WITH LEUKEMIA 97
Nephrotoxicity of amphotericin B desoxycholate 96
[Antibiotic prophylaxis in the control of infections in surgery: comparison of treatment in different types of surgery]. 96
[Infectious complications in patients with malignant blood diseases]. 95
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience 95
Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study 94
Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia. 92
TTV and CMV viral load dynamics. Which emerges first during immunosuppression 91
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment 91
Neutropenic enterocolitis in patients with acute leukemia: Prognostic significance of bowel wall thickening detected by ultrasonography 91
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies 90
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL) 90
Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity 90
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 89
Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemolyticus, S. epidermidis and S. aureus 89
INVASIVE FUSARIUM-SOLANI INFECTIONS IN PATIENTS WITH ACUTE-LEUKEMIA 88
Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia. 88
Approccio diagnostico e terapeutico al paziente oncoematologico con neutropenia e febbre 87
HOSPITAL-ACQUIRED CRYPTOSPORIDIOSIS IN A BONE-MARROW TRANSPLANTATION UNIT 86
Teicoplanin in the treatment of Gram-positive bacteraemia in neutropenic patients 86
Le infezioni fungine nel paziente granulocitopenico 85
Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies 85
Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia. 84
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report 83
Catheter related right-sided endocarditis in bone marrow recipients 83
Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomicosis during caspofungin therapy in a patients with severe aplastic anemia who underwent stem cell transplantation 83
Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients. 82
Complete remission obtained with azacitidine in a patient with concomitant therapy related myeloid neoplasm and pulmonary mucormycosis. 81
New quinolones against coagulase-negative Staphylococcus blood isolates: in vitro sensitivity and slime production. 80
Pefloxacin in the treatment of Gram- negative infections in patients with haematologic diseases 80
Species identification and detection of oxacillin resistence in coagulase-negative Sthaphylococcus blood isolates from neutropenic patients 77
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind multicenter trial 76
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. 76
High dose idarubicine, busulphan e melphalan as conditioning for autilogous blood stem cell transplantation in multiple myeloma. A feasibility study 76
Utilità della correzione chirurgica del difetto interventricolare per via transatriale 75
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study 73
Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus. 70
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: Factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias 70
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study 69
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study 67
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two italian centres. Clin Microbiol Infect. 2005; 11: 505-7. 67
Teicoplanin in the treatment of Gram-positive endocarditis 67
Neutropenic enterocolitis in acute leukemia: diagnostic and therapeutic dilemma 66
Early and late complications related to central venous catheters in hematological malignancies: a retrospective analysis of 1102 patients. 66
Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. 65
COVID-19 pneumonia and pulmonary microembolism in a patient with B-thalassemia major 64
In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies 63
Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients. 63
null 63
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer 62
Infezione di cute e tessuti molli negli immunocompromessi 62
Reply to J.H. Joshi 62
Prevention of bacterial infection in neutropenic patients with hematologic malignancies: A randomized, multicenter trial comparing norfloxacin with ciprofloxacin 62
Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients. 59
Candida colonization and systemic infection in neutropenic patients 58
Relationship between cytomegalovirus infection of peripheral blood leukocytes and bone marrow cells in haematopoietic stem cell transplant recipients 58
Rik factors for nephrotoxicity associated with conventional amphotericin b therapy 57
Prophylaxis and treatment of bacterial infections: do we need new strategies? 56
null 53
Pneumonia in allogeneic and autologous bone marrow recipients: a retrospective study 51
Totale 9.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 31 35
2021/20221.014 6 65 94 38 136 44 35 100 72 101 123 200
2022/20231.169 243 246 39 149 91 144 12 56 123 33 22 11
2023/2024413 35 66 14 39 34 43 13 19 7 61 31 51
2024/20251.602 52 67 55 35 78 83 97 82 294 178 104 477
2025/20263.557 392 137 313 355 485 258 526 244 318 355 174 0
Totale 10.311